Neurocrine Biosciences Other noncurrent liabilities increased by 276.9% to $19.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.6%, from $15.60M to $19.60M.
other_other_noncurrent_liabilities| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $5.50M | $15.60M | $27.10M | $200.00K | $5.20M | $19.60M |
| QoQ Change | — | +183.6% | +73.7% | -99.3% | >999% | +276.9% |
| YoY Change | — | — | — | — | -5.5% | +25.6% |